
    
      This will be a prospective, multi-center, randomized, open-label, within-patient paired
      design study. The primary purpose is to analyze cardiac tissue obtained after application of
      Anginera to adults with an LVAD as a bridge to transplant, to determine effects on various
      markers.
    
  